Case and Research Letter
Refractory solar urticaria successfully treated with omalizumab with normalization of phototest
Urticaria solar refractaria tratada satisfactoriamente con omalizumab y normalización del fototest
A. Combalia
, C. Fernández-Sartorio, P. Aguilera
Autor para correspondencia
Dermatology Department, Hospital Clínic de Barcelona, Barcelona, Spain
Leído
5738
Vecesse ha leído el artículo
2017
Total PDF
3721
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 26 | 3 | 29 |
| 2025 5 | 220 | 37 | 257 |
| 2025 4 | 211 | 22 | 233 |
| 2025 3 | 142 | 27 | 169 |
| 2025 2 | 138 | 25 | 163 |
| 2025 1 | 74 | 29 | 103 |
| 2024 12 | 75 | 23 | 98 |
| 2024 11 | 95 | 54 | 149 |
| 2024 10 | 65 | 31 | 96 |
| 2024 9 | 68 | 18 | 86 |
| 2024 8 | 98 | 52 | 150 |
| 2024 7 | 82 | 41 | 123 |
| 2024 6 | 85 | 38 | 123 |
| 2024 5 | 85 | 41 | 126 |
| 2024 4 | 70 | 31 | 101 |
| 2024 3 | 74 | 31 | 105 |
| 2024 2 | 56 | 26 | 82 |
| 2024 1 | 48 | 38 | 86 |
| 2023 12 | 44 | 18 | 62 |
| 2023 11 | 51 | 27 | 78 |
| 2023 10 | 51 | 24 | 75 |
| 2023 9 | 53 | 33 | 86 |
| 2023 8 | 49 | 19 | 68 |
| 2023 7 | 64 | 32 | 96 |
| 2023 6 | 40 | 19 | 59 |
| 2023 5 | 51 | 24 | 75 |
| 2023 4 | 41 | 29 | 70 |
| 2023 3 | 38 | 20 | 58 |
| 2023 2 | 44 | 25 | 69 |
| 2022 1 | 27 | 24 | 51 |
| 2022 12 | 42 | 37 | 79 |
| 2022 11 | 22 | 31 | 53 |
| 2022 10 | 35 | 23 | 58 |
| 2022 9 | 22 | 39 | 61 |
| 2022 8 | 29 | 35 | 64 |
| 2022 7 | 16 | 35 | 51 |
| 2022 6 | 20 | 24 | 44 |
| 2022 5 | 49 | 42 | 91 |
| 2022 4 | 50 | 35 | 85 |
| 2022 3 | 59 | 41 | 100 |
| 2022 2 | 49 | 23 | 72 |
| 2021 1 | 54 | 30 | 84 |
| 2021 12 | 36 | 37 | 73 |
| 2021 11 | 40 | 44 | 84 |
| 2021 10 | 46 | 51 | 97 |
| 2021 9 | 36 | 33 | 69 |
| 2021 8 | 21 | 32 | 53 |
| 2021 7 | 19 | 27 | 46 |
| 2021 6 | 35 | 25 | 60 |
| 2021 5 | 39 | 51 | 90 |
| 2021 4 | 77 | 84 | 161 |
| 2021 3 | 55 | 38 | 93 |
| 2021 2 | 45 | 29 | 74 |
| 2020 1 | 29 | 15 | 44 |
| 2020 12 | 36 | 23 | 59 |
| 2020 11 | 25 | 21 | 46 |
| 2020 10 | 24 | 12 | 36 |
| 2020 9 | 29 | 19 | 48 |
| 2020 8 | 34 | 16 | 50 |
| 2020 7 | 26 | 22 | 48 |
| 2020 6 | 29 | 45 | 74 |
| 2020 5 | 17 | 16 | 33 |
| 2020 4 | 28 | 12 | 40 |
| 2020 3 | 20 | 12 | 32 |
| 2020 2 | 3 | 0 | 3 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 4 | 0 | 4 |
| 2019 11 | 6 | 0 | 6 |
| 2019 9 | 4 | 0 | 4 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 4 | 0 | 4 |
| 2019 5 | 2 | 0 | 2 |
| 2019 4 | 2 | 0 | 2 |
| 2019 2 | 3 | 0 | 3 |
| 2019 1 | 1 | 0 | 1 |
| 2018 12 | 3 | 0 | 3 |
| 2018 11 | 3 | 0 | 3 |
| 2018 10 | 3 | 0 | 3 |
| 2018 9 | 3 | 0 | 3 |
| 2018 2 | 12 | 4 | 16 |
| 2018 1 | 20 | 3 | 23 |
| 2017 12 | 47 | 6 | 53 |
| 2017 11 | 16 | 8 | 24 |
| 2017 10 | 14 | 15 | 29 |
| 2017 9 | 19 | 13 | 32 |
| 2017 8 | 38 | 20 | 58 |
| 2017 7 | 39 | 27 | 66 |
| 2017 6 | 5 | 1 | 6 |
Mostrar todo
